The identification of several blood types has transformed medicine; nonetheless, within the wide range of blood types, there is one anomaly that still fascinates researchers and practitioners of medicine: the Bombay blood group. 

Blood types provide insights regarding our genetic variety and lineage beyond simply serving as biological markers.

These lesser-known blood groups, often referred to as rare blood types, offer a glimpse into the diversity of human biology and pose unique challenges in transfusion medicine.

One in 10,000 persons in India and one in a million people in Europe have the Bombay blood group.

What is Bombay Blood Group?

The Bombay blood group, which is sometimes referred to as the hh blood group or the Oh phenotype, is a very uncommon blood type that can be identified by red blood cells' lack of antigens A, B, and H.

The Bombay blood group was found in 1952 in Bombay, India, by doctors Y. M. Bhende and S. G. Bhatia.

"Bombay phenotype" refers to people whose red blood cells do not contain the H antigen; the name comes from the city where it was initially found. 

It is still one of the rarest blood types in the world. Because they do not have the H antigen, people with this blood type cannot get normal blood transfusions.

According to one study, the best way to identify the Bombay Oh Blood group is to perform a full immunohematology workup (Blood Group: Forward and Reverse with Auto control) and test for secretary status (with controls) using standardized agglutination technologies.

When blood from Bombay phenotypes is mixed with samples from any other ABO blood group, the presence of anti-H antibodies, primarily IgM natural antibodies, can result in serious hemolytic transfusion events with intravascular hemolysis.

Learning about the Genetics

The FUT1 and FUT2 genes encode enzymes necessary for the manufacture of H antigen, which is a precursor to A and B antigens, and this rarity is a result of these mutations.

Due to the autosomal recessive nature of the Bombay blood group, a child cannot express the phenotype unless both parents possess the gene.

The Difficulties of Transfusion Medicine

In transfusion medicine, the lack of Bombay blood group donors presents serious challenges, especially in emergency scenarios where suitable blood may be hard to come by.

Moreover, finding appropriate donors is made more difficult by the lack of knowledge and regular screening for this rare blood type.

The Red blood cells of bombay phenotype lack the A and B antigens because these antigens are not produced without the H antigen precursor.

Therefore, these people can only receive blood from another person who carries the Bombay phenotype, as they create anti-H, anti-A, and anti-B.

They can only be transfused with RBCs that do not have the H, A, or B antigens.

Because people in this blood type have antibodies against certain antigens, transfusions can be difficult and thorough compatibility testing is required.

Relevant Studies and Evaluations:

One literature review claims that the Bombay blood group is an uncommon occurrence that might cause deadly consequences for both mothers and fetuses if it is not identified during prenatal booking checks with a high index of suspicion.

In order to reduce the rare consequences of blood transfusion responses and hemolytic illness of the fetus and baby, anti-H blood arrangements should be made during pregnancy.

As per a study Bombay blood group would be classified as O group during cell grouping or forward grouping since it would not react to anti-A and anti-B antibodies as a typical O group would.

The results of a cross-matching procedure using various O group blood bags would indicate cross-reactivity or incompatibility.

So in many cases bombay blood group is mistaken with O group.

It can be said then, that grouping alone is insufficient prior to blood transfusion. To identify this uncommon blood group, cross matching is required.

To confirm the diagnosis, serum grouping or reverse grouping should be carried out.

Testing should be done to determine whether the patient's first degree relatives have the Bombay blood group.

People with Bombay blood group red blood cells can only be compatible with the serum of another person who has the H/H or Bombay blood type, according to a study.

People who have the unique Bombay phenotype can only receive blood from other people who also have the Bombay phenotype.

However, they can donate blood to others in the ABO blood group system.

Based on another study, the Bombay anti-H antibodies can lyse erythrocytes and are immunoglobulins of the IgM or IgG classes.

Acute normovolemic hemodilution may be used during surgery if blood loss is suspected and no Bombay phenotype blood is available.

This entails drawing blood from the patient while using crystalloids or colloids to maintain normovolemia following the induction of anesthesia.

According to one study, there is no established link between the Bombay phenotype and any diseases.

However, it has been noted that the risk of bleeding issues is higher in all type O blood individuals, including those with the Bombay phenotype.

Pre-operative autologous blood arrangements and the administration of erythropoietin can help patients with Bombay blood group undergoing heart surgery. Blood loss from minimally invasive surgery is lower.

Clinical Supervision and Intervention

In times of necessity, blood banks can create exchange programs and keep track of unusual blood types among their donors. For unusual blood types like bombay blood type cryopreservation facilities can also be helpful.

For this patient type, autologous blood transfusions may be a good substitute during elective procedures.'

For the treatment of coagulopathies, patients with this phenotype can receive cryoprecipitate and fresh frozen plasma.

Furthermore, improvements in patient care and safety have been made possible by advances in molecular diagnostics, which have made it easier to identify uncommon blood types.

Conclusion

Within the field of transfusion medicine, the Bombay blood group continues to be a fascinating outlier that provides insights into the intricacies of human blood typing and compatibility.

Future investigation into the genetic makeup and potential therapeutic applications of the Bombay blood group could potentially enhance transfusion protocols and enhance patient outcomes.

In addition, in order to guarantee prompt and suitable management of patients with the Bombay blood group, it is imperative that medical experts and the general public be made aware of this uncommon blood type.

Our capacity to handle the particular difficulties this uncommon phenotype poses in clinical practice will advance along with our comprehension of it, ultimately improving the efficacy and safety of blood transfusions for all patients.

Check out this interesting video podcast to know more about this: